(Fund7’s Portfolio)

Cardiospire has developed a proprietary Non-invasive Hemodynamic Monitoring technology.
Their technology makes it possible to displace the catheterization risk, to remove the guesswork from hemodynamic management, and to de-risk unknown cardiopulmonary status, by providing high-fidelity stroke volume, cardiac output and pulmonary artery pressure in ventilated patients non-invasively